Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients
Part of paid clinical trials in Ocoee, Florida.
- Sponsor
- US Oncology Research
- Study ID
- NCT00254163
- Phase
- PHASE3
- Status
- Completed
Conditions
- B-Cell Chronic Lymphocytic Leukemia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Fludarabine — DRUG
- Cyclophosphamide — DRUG
- Rituximab — DRUG
- Pentostatin — DRUG
Study Details
The purpose of this research study is to find out what effects (good and bad) the combination of Nipent+Cytoxan+Rituxan has on CLL cancer compared to Fludara+Cytoxan+Rituxan. While all of these drugs are approved by the Food and Drug Administration (FDA) for the treatment of other cancers, these combinations are experimental for the treatment of CLL.
Key Dates
- Start date
- Dec 31, 2003
- Status verified
- Sep 2016
- Primary completion
- Sep 30, 2011
- Completion
- Sep 30, 2011
Study Design
- Enrollment
- 184 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Fludarabine, Cyclophosphamide, and RituximabFludarabine, Cyclophosphamide, and Rituximab (dosage based on day in cycle)
- Experimental: Pentostatin, Cyclophosphamide, and RituximabPentostatin, Cyclophosphamide, and Rituximab (dosage depends on day in cycle)
Primary Outcome Measure
Infection Rate [ Time Frame: 6 cycles of 28-day for FCR and 8 cycles of 21-day for PCR, or until PD, CR, or intolerable toxicity ]
Locations (11)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cancer Centers of Florida, P.A. | Ocoee | Florida | 34761 | - |
| Hope Center | Terre Haute | Indiana | 47802 | - |
| Alliance Hematology Oncology PA | Westminster | Maryland | 21157 | - |
| St Joseph Oncology, Inc | Saint Joseph | Missouri | 64507 | - |
| New York Oncology Hematology, PC | Albany | New York | 12208 | - |
| Northwestern Carolina Oncology Hemato | Hickory | North Carolina | 28602 | - |
| Medical Oncology Associates | Kingston | Pennsylvania | 18704 | - |
| South Texas Cancer Center-McAllen | McAllen | Texas | 78503 | - |
| Texas Oncology Cancer Center-Sugar Land | Sugar Land | Texas | 77479 | - |
| Cancer Care Northwest-South | Spokane | Washington | 99202 | - |
| Yakima Valley Mem Hosp/North Star Lodge | Yakima | Washington | 98902 | - |
Find similar trials in Ocoee, FL
Related Studies
- A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin LymphomaPHASE3 · Recruiting · Grifols Therapeutics LLC · Huntington Park, California
- Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for LeukemiasPHASE1/PHASE2 · Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland